| 中文名 | N-脱羟乙基达沙替尼 |
|---|---|
| 英文名 | N-(2-chloro-6-methylphenyl)-2-[(2-methyl-6-piperazin-1-ylpyrimidin-4-yl)amino]-1,3-thiazole-5-carboxamide |
| 英文别名 |
N-(2-CHLORO-6-METHYLPHENYL)-2-[[2-METHYL-6-(PIPERAZIN-1-YL)-PYRIMIDIN-4-YL]AMINO]-5-THIAZOLECARBOXAMIDE
Dasatinib metabolite M4 N-(2-chloro-6-methylphenyl)-2-(2-methyl-6-(piperazin-1-yl)pyrimidin-4-ylamino)thiazole-5-carboxamide N-(2-chloro-6-methylphenyl)-2-[[2-methyl-6-(1-piperazinyl)-4-pyrimidinyl]amino]-5-thiazolecarboxamide N-Deshydroxyethyl Dasatinib Dasatinib Impurity 6 Target Protein-binding moiety 8 |
| 描述 | Target Protein-binding moiety 8 是一种能够与 BCR-ABL 结合的结构,用于抑制 BCR-ABL 的活性。 |
|---|---|
| 相关类别 | |
| 靶点 |
BCR-ABL[1] |
| 体外研究 | 靶蛋白结合部分8(化合物8)是与BCR-ABL结合的化合物,用于抑制BCR-ABL活性。 |
| 参考文献 |
| 密度 | 1.404g/cm3 |
|---|---|
| 熔点 | >300ºC |
| 分子式 | C20H22ClN7OS |
| 分子量 | 443.95300 |
| 精确质量 | 443.13000 |
| PSA | 123.31000 |
| LogP | 4.14860 |
| 外观性状 | 固体 |
| 折射率 | 1.69 |
| 储存条件 | 2-8°C,密封,干燥 |
|
~20%
910297-51-7 |
| 文献:Arora, Vinod Kumar; Christopher, Lisa Joy; Cui, Donghui; Li, Wenying Patent: US2006/211705 A1, 2006 ; Location in patent: Page/Page column 28 ; |
|
~79%
910297-51-7 |
| 文献:Veach, Darren R.; Namavari, Mohammad; Pillarsetty, Nagavarakishore; Santos, Elmer B.; Beresten-Kochetkov, Tatiana; Lambek, Caryl; Punzalan, Blesida J.; Antczak, Christophe; Smith-Jones, Peter M.; Djaballah, Hakim; Clarkson, Bayard; Larson, Steven M. Journal of Medicinal Chemistry, 2007 , vol. 50, # 23 p. 5853 - 5857 |
| 上游产品 2 | |
|---|---|
| 下游产品 1 | |